Ex­sci­en­tia wants to bring its AI/ML ap­proach in­to the world of bi­o­log­ics. It's start­ing with an­ti­bod­ies

Ex­sci­en­tia is look­ing at break­ing out of small mol­e­cule R&D.

The UK biotech an­nounced Thurs­day that it is ex­pand­ing its R&D ef­forts in­to bi­o­log­ics, more specif­i­cal­ly an­ti­bod­ies, look­ing to im­ple­ment pre­ci­sion en­gi­neer­ing and uti­lize in sil­i­co screen­ing. And in or­der to put the ex­pan­sion in­to place, Ex­sci­en­tia al­so an­nounced that it will be adding new build­ing space to its head­quar­ters to house the new lab­o­ra­to­ry.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER